AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $10,657,000 | +55.8% | 158,029 | +6.5% | 0.01% | +60.0% |
| Q4 2018 | $6,842,000 | -70.2% | 148,394 | -50.2% | 0.01% | -37.5% |
| Q3 2018 | $22,982,000 | +85.9% | 298,000 | +103.0% | 0.01% | 0.0% |
| Q2 2018 | $12,365,000 | +23.9% | 146,798 | +20.3% | 0.01% | +14.3% |
| Q1 2018 | $9,978,000 | +61.1% | 122,013 | +12.6% | 0.01% | +75.0% |
| Q4 2017 | $6,195,000 | -17.7% | 108,369 | -3.9% | 0.00% | -20.0% |
| Q3 2017 | $7,530,000 | +24.8% | 112,813 | -3.8% | 0.01% | +25.0% |
| Q2 2017 | $6,033,000 | +15.8% | 117,265 | +31.4% | 0.00% | 0.0% |
| Q1 2017 | $5,211,000 | +33.3% | 89,235 | -4.8% | 0.00% | +33.3% |
| Q4 2016 | $3,910,000 | -12.3% | 93,697 | +11.0% | 0.00% | 0.0% |
| Q3 2016 | $4,459,000 | +31.8% | 84,412 | +4.5% | 0.00% | 0.0% |
| Q2 2016 | $3,384,000 | +11.2% | 80,776 | +7.8% | 0.00% | +50.0% |
| Q1 2016 | $3,042,000 | -39.0% | 74,924 | -2.4% | 0.00% | -50.0% |
| Q4 2015 | $4,985,000 | -8.1% | 76,780 | -0.1% | 0.00% | 0.0% |
| Q3 2015 | $5,427,000 | -54.5% | 76,880 | -28.4% | 0.00% | -50.0% |
| Q2 2015 | $11,926,000 | +158.1% | 107,306 | +119.0% | 0.01% | +166.7% |
| Q1 2015 | $4,621,000 | -14.3% | 49,001 | +1.8% | 0.00% | -25.0% |
| Q4 2014 | $5,395,000 | +76.8% | 48,151 | -3.2% | 0.00% | +100.0% |
| Q3 2014 | $3,051,000 | +31.1% | 49,735 | -2.1% | 0.00% | 0.0% |
| Q2 2014 | $2,328,000 | +112.2% | 50,807 | +81.2% | 0.00% | +100.0% |
| Q1 2014 | $1,097,000 | +63.5% | 28,032 | 0.0% | 0.00% | – |
| Q4 2013 | $671,000 | +41.9% | 28,032 | +65.6% | 0.00% | – |
| Q3 2013 | $473,000 | – | 16,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |